144 related articles for article (PubMed ID: 8031055)
1. Comparative serum bactericidal activities of three doses of ciprofloxacin administered intravenously.
Dan M; Poch F; Quassem C; Kitzes R
Antimicrob Agents Chemother; 1994 Apr; 38(4):837-41. PubMed ID: 8031055
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin.
Paradis D; Vallée F; Allard S; Bisson C; Daviau N; Drapeau C; Auger F; LeBel M
Antimicrob Agents Chemother; 1992 Oct; 36(10):2085-92. PubMed ID: 1444289
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers.
Israel D; Gillum JG; Turik M; Harvey K; Ford J; Dalton H; Towle M; Echols R; Heller AH; Polk R
Antimicrob Agents Chemother; 1993 Oct; 37(10):2193-9. PubMed ID: 8257144
[TBL] [Abstract][Full Text] [Related]
4. Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin.
Echols R; Weinstein MP; O'Keeffe B; Shah A; Heller AH
J Antimicrob Chemother; 1994 Jan; 33(1):111-8. PubMed ID: 8157551
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal activity of ciprofloxacin compared with that of cefotaxime in normal volunteers.
Standiford HC; Drusano GL; Forrest A; Tatem B; Plaisance K
Antimicrob Agents Chemother; 1987 Aug; 31(8):1177-82. PubMed ID: 3631942
[TBL] [Abstract][Full Text] [Related]
6. Serum inhibitory and bactericidal activity of ciprofloxacin following intravenous administration.
Dudley MN; Mandler HD; Mayer KH; Zinner SH
DICP; 1989 Jun; 23(6):456-60. PubMed ID: 2741478
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion and bactericidal activity of intravenous ciprofloxacin compared with oral ciprofloxacin.
Naber KG; Theuretzbacher U; Moneva-Koucheva G; Stass H
Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):783-9. PubMed ID: 10614952
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.
Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 1995 Nov; 39(11):2503-10. PubMed ID: 8585734
[TBL] [Abstract][Full Text] [Related]
9. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.
Well M; Naber KG; Kinzig-Schippers M; Sörgel F
Int J Antimicrob Agents; 1998 Apr; 10(1):31-8. PubMed ID: 9624541
[TBL] [Abstract][Full Text] [Related]
10. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.
Paulfeuerborn W; Müller HJ; Borner K; Koeppe P; Lode H
Antimicrob Agents Chemother; 1993 Sep; 37(9):1835-41. PubMed ID: 8239592
[TBL] [Abstract][Full Text] [Related]
12. Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
Wagenlehner FM; Wydra S; Onda H; Kinzig-Schippers M; Sörgel F; Naber KG
Antimicrob Agents Chemother; 2003 Dec; 47(12):3789-94. PubMed ID: 14638484
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar.
Hyatt JM; Nix DE; Schentag JJ
Antimicrob Agents Chemother; 1994 Dec; 38(12):2730-7. PubMed ID: 7695254
[TBL] [Abstract][Full Text] [Related]
14. Comparative assessment of the pharmacokinetics and pharmacodynamics of ciprofloxacin after single i.v. doses of 200 and 400mg.
Garraffo R; Drugeon HB
Drugs; 1995; 49 Suppl 2():317-20. PubMed ID: 8549347
[No Abstract] [Full Text] [Related]
15. Bactericidal activity of ciprofloxacin in serum and urine against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus faecalis.
Lagast H; Husson M; Klastersky J
J Antimicrob Chemother; 1985 Sep; 16(3):341-7. PubMed ID: 2932416
[TBL] [Abstract][Full Text] [Related]
16. Serum bactericidal activity from intravenous ciprofloxacin and azlocillin given alone and in combination to healthy subjects.
Orlando PL; Barriere SL; Hindler JA; Frost RW
Diagn Microbiol Infect Dis; 1990; 13(2):93-7. PubMed ID: 2114954
[TBL] [Abstract][Full Text] [Related]
17. Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteers.
Machka K; Milatovic D
Eur J Clin Microbiol; 1987 Feb; 6(1):59-62. PubMed ID: 3106034
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion.
Burgess DS; Hastings RW; Hardin TC
Clin Ther; 2000 Jan; 22(1):66-75. PubMed ID: 10688391
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the bactericidal activity of trovafloxacin and ciprofloxacin, alone and in combination with cefepime, against Pseudomonas aeruginosa.
McNabb J; Quintiliani R; Nightingale CH; Nicolau DP
Chemotherapy; 2000; 46(6):383-9. PubMed ID: 11053903
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacodynamics of gatifloxacin and ciprofloxacin in an in vitro dynamic model: prediction of equiefficient doses and the breakpoints of the area under the curve/MIC ratio.
Vostrov SN; Kononenko OV; Lubenko IY; Zinner SH; Firsov AA
Antimicrob Agents Chemother; 2000 Apr; 44(4):879-84. PubMed ID: 10722485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
